These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31012882)

  • 21. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β blockade-improved chemo-immunotherapy with pH/ROS cascade-responsive micelle via tumor microenvironment remodeling.
    Dai L; Li X; Zheng X; Fu Z; Yao M; Meng S; Zhang J; Han B; Gao Q; Chang J; Cai K; Yang H
    Biomaterials; 2021 Sep; 276():121010. PubMed ID: 34247042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death.
    Tu K; Deng H; Kong L; Wang Y; Yang T; Hu Q; Hu M; Yang C; Zhang Z
    ACS Appl Mater Interfaces; 2020 Apr; 12(14):16018-16030. PubMed ID: 32192326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid polymeric micelles based on bioactive polypeptides as pH-responsive delivery systems against melanoma.
    Wang QM; Gao Z; Liu S; Fan B; Kang L; Huang W; Jin M
    Biomaterials; 2014 Aug; 35(25):7008-21. PubMed ID: 24875757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.
    Schmid D; Park CG; Hartl CA; Subedi N; Cartwright AN; Puerto RB; Zheng Y; Maiarana J; Freeman GJ; Wucherpfennig KW; Irvine DJ; Goldberg MS
    Nat Commun; 2017 Nov; 8(1):1747. PubMed ID: 29170511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of 5'-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy.
    Jacobson ME; Wang-Bishop L; Becker KW; Wilson JT
    Biomater Sci; 2019 Jan; 7(2):547-559. PubMed ID: 30379158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.
    Jeanbart L; Kourtis IC; van der Vlies AJ; Swartz MA; Hubbell JA
    Cancer Immunol Immunother; 2015 Aug; 64(8):1033-46. PubMed ID: 25982370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folated pH-degradable nanogels for the simultaneous delivery of docetaxel and an IDO1-inhibitor in enhancing cancer chemo-immunotherapy.
    Qiao H; Chen X; Chen E; Zhang J; Huang D; Yang D; Ding Y; Qian H; Feijen J; Chen W
    Biomater Sci; 2019 Jun; 7(7):2749-2758. PubMed ID: 30997445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiency.
    Chen WL; Yang SD; Li F; Li JZ; Yuan ZQ; Zhu WJ; Liu Y; Zhou XF; Liu C; Zhang XN
    Int J Pharm; 2016 Sep; 511(2):728-40. PubMed ID: 27484835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
    Wakimoto H; Abe J; Tsunoda R; Aoyagi M; Hirakawa K; Hamada H
    Cancer Res; 1996 Apr; 56(8):1828-33. PubMed ID: 8620500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro.
    Kitoh Y; Saio M; Gotoh N; Umemura N; Nonaka K; Bai J; Vizkeleti L; Torocsik D; Balazs M; Adany R; Takami T
    Int J Oncol; 2011 May; 38(5):1409-19. PubMed ID: 21373754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-gamma.
    Lei H; Ju DW; Yu Y; Tao Q; Chen G; Gu S; Hamada H; Cao X
    Gene Ther; 2000 Apr; 7(8):707-13. PubMed ID: 10800095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
    Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
    J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.
    Zhu WJ; Yang SD; Qu CX; Zhu QL; Chen WL; Li F; Yuan ZQ; Liu Y; You BG; Zhang XN
    Int J Nanomedicine; 2017; 12():3375-3393. PubMed ID: 28490877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy.
    Jiang J; Zhang Y; Peng K; Wang Q; Hong X; Li H; Fan G; Zhang Z; Gong T; Sun X
    Acta Biomater; 2017 Oct; 61():114-123. PubMed ID: 28483693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
    Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
    J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy.
    Li B; VanRoey MJ; Jooss K
    Clin Immunol; 2007 May; 123(2):155-65. PubMed ID: 17320482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS; Weber S; Gan J; Rakhmilevich AL; Mahvi DM
    Cancer Gene Ther; 1999; 6(1):81-8. PubMed ID: 10078967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.